Galapagos NV (NASDAQ:GLPG) is one of the 7 Fastest Growing European Stocks to Invest In. On March 31, 2026, Galapagos NV ...
Discover the heartwarming story of 158 giant tortoises returning to their ancestral home on Floreana Island after nearly two ...
Gilead Sciences plans to acquire Ouro Medicines for up to about $2.18 billion and develop the assets from the deal in a ...
New collaboration structure achieves meaningfully improved financial terms and flexibility for Galapagos Following this transaction, the Company ...
Galapagos (NASDAQ:GLPG) said it has entered into a binding collaboration agreement with Gilead focused on Gamgertamig, a BCMA ...
Gilead Sciences is paying $1.67 billion for a T-cell engager (TCE) company via a front-loaded deal that could also give new ...
Almost 200 years after Charles Darwin’s groundbreaking trip to the Galápagos islands, a graduate student from San Francisco ...
The Galapagos can be an overwhelming experience for clients, albeit the experience of a lifetime. And having that opportunity ...
Galapagos (GLPG) backs Gilead’s Ouro Medicines deal, sharing $1.675B upfront and milestones, plus 20–23% royalties on gamgertamig—read more.
Gilead to acquire an immunology biotech and Merck partners with Flagship company on IBD targets. Plus: Do you have what it ...
Galapagos intends to enter into a strategic collaboration with Gilead following Gilead's acquisition of Ouro MedicinesNew partnership structure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results